var data={"title":"Arrhythmias during anesthesia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Arrhythmias during anesthesia</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/contributors\" class=\"contributor contributor_credentials\">Emily Methangkool, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/contributors\" class=\"contributor contributor_credentials\">Aman Mahajan, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/contributors\" class=\"contributor contributor_credentials\">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/contributors\" class=\"contributor contributor_credentials\">Nancy A Nussmeier, MD, FAHA</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 10, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H3340866184\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intraoperative arrhythmias are common; nearly 11 percent of patients experience an abnormal heart rhythm during general anesthesia [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Both tachyarrhythmias (heart rate [HR] &gt;120 beats per minute [bpm]) and bradyarrhythmias (HR &lt;40 bpm) occur. While most intraoperative arrhythmias are transient and clinically insignificant, they may indicate underlying pathology (eg, myocardial ischemia, electrolyte abnormalities). Occasionally an arrhythmia causes intraoperative hemodynamic instability and postoperative morbidity.</p><p>This topic reviews etiologies, recognition, and acute management of intraoperative cardiac arrhythmias. Other topics address advanced cardiac life support and further treatment of specific arrhythmias:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=overview-of-the-acute-management-of-tachyarrhythmias\" class=\"medical medical_review\">&quot;Overview of the acute management of tachyarrhythmias&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=sinus-bradycardia\" class=\"medical medical_review\">&quot;Sinus bradycardia&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=second-degree-atrioventricular-block-mobitz-type-i-wenckebach-block\" class=\"medical medical_review\">&quot;Second degree atrioventricular block: Mobitz type I (Wenckebach block)&quot;</a> and <a href=\"topic.htm?path=second-degree-atrioventricular-block-mobitz-type-ii\" class=\"medical medical_review\">&quot;Second degree atrioventricular block: Mobitz type II&quot;</a> and <a href=\"topic.htm?path=third-degree-complete-atrioventricular-block\" class=\"medical medical_review\">&quot;Third degree (complete) atrioventricular block&quot;</a>.) </p><p/><p class=\"headingAnchor\" id=\"H3806099833\"><span class=\"h1\">INTRAOPERATIVE DIAGNOSIS OF ARRHYTHMIAS</span></p><p class=\"headingAnchor\" id=\"H1282227149\"><span class=\"h2\">Standard electrocardiography</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The electrocardiogram (ECG) is continuously monitored for any patient receiving anesthetic agents. Both leads II and V<sub>5</sub> are employed in patients with risk factors for myocardial ischemia or arrhythmias [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/3\" class=\"abstract_t\">3</a>]. If a tachyarrhythmia or bradyarrhythmia develops that cannot be readily diagnosed, all available leads should be displayed on the monitor used in the perioperative setting and a 12-lead ECG should be obtained as soon as feasible to facilitate a correct diagnosis. (See <a href=\"topic.htm?path=monitoring-during-anesthesia#H2833091405\" class=\"medical medical_review\">&quot;Monitoring during anesthesia&quot;, section on 'Electrocardiogram'</a> and <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H295569606\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Monitoring for ischemia'</a>.)</p><p class=\"headingAnchor\" id=\"H3063513053\"><span class=\"h2\">Recognition of artifacts</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Notably, artifact due to electrocautery or pacing spikes can mimic ventricular tachycardia (VT) or ventricular fibrillation (VF). Ventricular-paced rhythms can also mimic VT. Stable waveforms from the pulse oximeter, intra-arterial catheter, <span class=\"nowrap\">and/or</span> central venous catheter may be helpful to distinguish artifact from a true arrhythmia. (See <a href=\"topic.htm?path=monitoring-during-anesthesia#H3268790241\" class=\"medical medical_review\">&quot;Monitoring during anesthesia&quot;, section on 'Sources of ECG artifact'</a>.)</p><p class=\"headingAnchor\" id=\"H1841031312\"><span class=\"h1\">CONTRIBUTING FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both atrial and ventricular arrhythmias, as well as cardiac arrest, are more likely to occur under certain conditions, including the presence of myocardial ischemia, extracardiac causes of cardiac pump failure, or respiratory, metabolic, volume status, or electrolyte abnormalities (<a href=\"image.htm?imageKey=CARD%2F52416\" class=\"graphic graphic_table graphicRef52416 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H914741745\"><span class=\"h2\">Myocardial ischemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Myocardial ischemia or infarction may be associated with atrial or ventricular arrhythmias including supraventricular tachycardia (SVT), conduction defect, or ectopic ventricular activity. Management of intraoperative myocardial ischemia is reviewed separately. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H319624669\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Treatment of ischemia'</a> and <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H31432339\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Management of arrhythmias'</a>.)</p><p class=\"headingAnchor\" id=\"H2266952436\"><span class=\"h2\">Extracardiac causes of cardiac pump failure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cardiac tamponade, pneumothorax, or pulmonary embolus are often associated with arrhythmias and hemodynamic instability that may progress to cardiac arrest.</p><p class=\"headingAnchor\" id=\"H1444722565\"><span class=\"h2\">Respiratory, metabolic, volume status, and electrolyte abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Potential contributing factors that may lead to arrhythmias and hemodynamic instability should be identified and corrected, including hypoxemia, acid-base disturbances (eg, hypocarbia, hypercarbia, acidemia), and volume depletion (eg, anemia, hypovolemia).</p><p>Also, electrolyte levels that should be checked for abnormalities include: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Potassium </strong>&mdash; Hypokalemia is associated with a variety of arrhythmias including premature atrial or ventricular ectopic beats, ventricular tachycardia (VT), or ventricular fibrillation (VF) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/4\" class=\"abstract_t\">4</a>]. Clinical manifestations and treatment are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-hypokalemia-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations and treatment of hypokalemia in adults&quot;</a>.) </p><p/><p class=\"bulletIndent1\">Hyperkalemia can lead to a variety of conduction abnormalities (eg, left bundle branch block, right bundle branch block, bifascicular block, advanced atrioventricular block), as well as sinus bradycardia, sinus arrest, ventricular tachycardia, ventricular fibrillation, and asystole. Clinical manifestations and treatment are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-of-hyperkalemia-in-adults#H4\" class=\"medical medical_review\">&quot;Clinical manifestations of hyperkalemia in adults&quot;, section on 'Cardiac manifestations'</a> and <a href=\"topic.htm?path=treatment-and-prevention-of-hyperkalemia-in-adults\" class=\"medical medical_review\">&quot;Treatment and prevention of hyperkalemia in adults&quot;</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Magnesium </strong>&mdash; Hypomagnesemia widens the QRS complex and increases the risk of a unique form of torsades de pointes (TdP), sustained atrial fibrillation (AF), frequent atrial or ventricular ectopic beats, and other ventricular arrhythmias [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/5\" class=\"abstract_t\">5</a>]. Clinical manifestations and treatment are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-of-magnesium-depletion#H1626324\" class=\"medical medical_review\">&quot;Clinical manifestations of magnesium depletion&quot;, section on 'Cardiovascular'</a> and <a href=\"topic.htm?path=evaluation-and-treatment-of-hypomagnesemia#H22105169\" class=\"medical medical_review\">&quot;Evaluation and treatment of hypomagnesemia&quot;, section on 'Patients with severe symptoms'</a>.) </p><p/><p class=\"bulletIndent1\">Hypermagnesemia (&gt;4 <span class=\"nowrap\">mEq/L)</span> may cause conduction defects, bradycardia, and hypotension. Symptoms typically resolve with cessation of magnesium therapy (eg, IV magnesium infusion for treatment of eclampsia or preeclampsia). In patients with renal insufficiency, isotonic IV fluids plus a loop diuretic (eg, <a href=\"topic.htm?path=furosemide-drug-information\" class=\"drug drug_general\">furosemide</a>) are administered, in addition to discontinuing any magnesium therapy. Postoperative dialysis is occasionally necessary. (See <a href=\"topic.htm?path=symptoms-of-hypermagnesemia#H3\" class=\"medical medical_review\">&quot;Symptoms of hypermagnesemia&quot;, section on 'Cardiovascular effects'</a> and <a href=\"topic.htm?path=causes-and-treatment-of-hypermagnesemia#H8\" class=\"medical medical_review\">&quot;Causes and treatment of hypermagnesemia&quot;, section on 'Treatment'</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Calcium </strong>&mdash; Hypocalcemia prolongs the QT interval (<a href=\"image.htm?imageKey=CARD%2F66206\" class=\"graphic graphic_waveform graphicRef66206 \">waveform 1</a>), but has less potential to trigger TdP compared with hypokalemia or hypomagnesemia. Clinical manifestations and treatment of severe acute or symptomatic hypocalcemia by administering intravenous (IV) calcium, as well as treatment of concurrent hypomagnesemia, are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-of-hypocalcemia#H7\" class=\"medical medical_review\">&quot;Clinical manifestations of hypocalcemia&quot;, section on 'Cardiovascular'</a> and <a href=\"topic.htm?path=treatment-of-hypocalcemia#H596754\" class=\"medical medical_review\">&quot;Treatment of hypocalcemia&quot;, section on 'Severe acute and/or symptomatic hypocalcemia'</a>.) &#160;</p><p/><p>Acute hypercalcemia shortens the myocardial action potential, as reflected in a shortened QT interval on the electrocardiogram (ECG). Although moderate hypercalcemia has no clinically important effects on cardiac conduction or the prevalence of supraventricular or ventricular arrhythmias, various cardiac arrhythmias and ST-segment elevation mimicking myocardial infarction have been described with severe hypercalcemia. Treatment is with saline hydration, as described separately. (See <a href=\"topic.htm?path=clinical-manifestations-of-hypercalcemia\" class=\"medical medical_review\">&quot;Clinical manifestations of hypercalcemia&quot;</a> and <a href=\"topic.htm?path=treatment-of-hypercalcemia#H4\" class=\"medical medical_review\">&quot;Treatment of hypercalcemia&quot;, section on 'Saline hydration'</a>.)</p><p class=\"headingAnchor\" id=\"H140932897\"><span class=\"h1\">ATRIAL TACHYARRHYTHMIAS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atrial tachyarrhythmias with a heart rate (HR) &gt;100 beats per minute (bpm) are common during anesthesia. These are classified as having a narrow QRS complex (QRS duration of &lt;120 ms), or wide QRS complex (QRS duration &gt;120 ms). (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-narrow-qrs-complex-tachycardias\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1843426040\"><span class=\"h2\">Urgent management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atrial tachyarrhythmias often terminate with vagal maneuvers or intravenous (IV) antiarrhythmic therapy with adenosine or <a href=\"topic.htm?path=verapamil-drug-information\" class=\"drug drug_general\">verapamil</a>, so that electrical cardioversion may not be required. However, if the patient becomes hemodynamically unstable (eg, hypotension, myocardial ischemia, pulmonary edema) <span class=\"nowrap\">and/or</span> the arrhythmia persists, electrical cardioversion is attempted unless it is certain that the rhythm is sinus tachycardia (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 1</a>) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/6\" class=\"abstract_t\">6</a>]. Details regarding management of cardioversion attempts are available elsewhere. (See <a href=\"topic.htm?path=cardioversion-for-specific-arrhythmias#H15\" class=\"medical medical_review\">&quot;Cardioversion for specific arrhythmias&quot;, section on 'Supraventricular tachycardia'</a>.) </p><p>In a hemodynamically stable patient, pharmacologic therapy (eg, adenosine, beta blockers such as <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a> or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a>, calcium channel blockers such as <a href=\"topic.htm?path=verapamil-drug-information\" class=\"drug drug_general\">verapamil</a> or <a href=\"topic.htm?path=diltiazem-drug-information\" class=\"drug drug_general\">diltiazem</a>, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>) is appropriate to control HR in most narrow or wide QRS complex atrial tachyarrhythmias with a rapid ventricular response (<a href=\"image.htm?imageKey=ANEST%2F110671\" class=\"graphic graphic_table graphicRef110671 \">table 2</a>). Specific circumstances are discussed below and in other topics. (See <a href=\"topic.htm?path=overview-of-the-acute-management-of-tachyarrhythmias\" class=\"medical medical_review\">&quot;Overview of the acute management of tachyarrhythmias&quot;</a>.) &#160;</p><p class=\"headingAnchor\" id=\"H584733046\"><span class=\"h2\">Narrow QRS complex atrial tachycardias</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Narrow QRS complex tachycardias originate above the atrioventricular (AV) node and activate a rapid ventricular response via an intact His-Purkinje conduction system. These supraventricular tachyarrhythmias (SVTs) can be classified as sinus tachycardia, atrial fibrillation, atrial flutter, AV nodal reentrant tachycardia (AVNRT), and multifocal atrial tachycardia. Specific intraoperative management differs for each type of arrhythmia. (See <a href=\"topic.htm?path=overview-of-the-acute-management-of-tachyarrhythmias\" class=\"medical medical_review\">&quot;Overview of the acute management of tachyarrhythmias&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H4049472522\"><span class=\"h3\">Sinus tachycardia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>During sedation or anesthesia, sinus tachycardia with a HR &gt;100 bpm (<a href=\"image.htm?imageKey=CARD%2F78938\" class=\"graphic graphic_waveform graphicRef78938 \">waveform 2</a>) most commonly occurs due to adrenergic stimulation resulting from inadequate anesthesia or analgesia, or as a reflex response to hypovolemia or anemia (typically due to blood loss). Other possible causes include hypoxemia, hypercarbia, sepsis, fever, myocardial ischemia, pulmonary embolism, hyperthyroidism, and malignant hyperthermia. (See <a href=\"topic.htm?path=sinus-tachycardia-evaluation-and-management\" class=\"medical medical_review\">&quot;Sinus tachycardia: Evaluation and management&quot;</a>.)</p><p>For most patients with mild sinus tachycardia (ie, HR 100 to 120 bpm), prompt treatment of the underlying causes (eg, deepening anesthesia or volume resuscitation) is adequate. For patients with known or possible ischemic heart disease or those with HR &gt;120 bpm, sinus tachycardia is treated with an IV beta blocker (eg, bolus doses of <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a> 10 to 25 mg or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a> 1 to 5 mg) to decrease HR to &le;80 bpm, provided that blood pressure (BP) is adequate and there are no contraindications. </p><p class=\"headingAnchor\" id=\"H2381976445\"><span class=\"h3\">Atrial fibrillation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atrial fibrillation (AF) may be chronic or occur with sudden onset during or shortly after surgery (<a href=\"image.htm?imageKey=CARD%2F73958\" class=\"graphic graphic_waveform graphicRef73958 \">waveform 3</a> and <a href=\"image.htm?imageKey=CARD%2F62698\" class=\"graphic graphic_waveform graphicRef62698 \">waveform 4</a> and <a href=\"image.htm?imageKey=CARD%2F53988\" class=\"graphic graphic_waveform graphicRef53988 \">waveform 5</a>) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/7,8\" class=\"abstract_t\">7,8</a>]. (See <a href=\"topic.htm?path=the-electrocardiogram-in-atrial-fibrillation\" class=\"medical medical_review\">&quot;The electrocardiogram in atrial fibrillation&quot;</a>.) </p><p>Treatment of AF depends upon hemodynamic stability (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 1</a>). AF with a ventricular rate &lt;120 bpm is often tolerated well, whereas a rapid ventricular rate &gt;150 bpm is usually associated with hypotension. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H12\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Tachycardia'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hemodynamic instability with a rapid ventricular response (&ge;120 bpm) </strong>&mdash; Patients with new-onset AF who are hemodynamically unstable should undergo immediate synchronized cardioversion (<a href=\"image.htm?imageKey=CARD%2F103268\" class=\"graphic graphic_figure graphicRef103268 \">figure 1</a>). (See <a href=\"topic.htm?path=basic-principles-and-technique-of-electrical-cardioversion-and-defibrillation\" class=\"medical medical_review\">&quot;Basic principles and technique of electrical cardioversion and defibrillation&quot;</a> and <a href=\"topic.htm?path=atrial-fibrillation-cardioversion-to-sinus-rhythm\" class=\"medical medical_review\">&quot;Atrial fibrillation: Cardioversion to sinus rhythm&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hemodynamic stability with a rapid ventricular response (&ge;120 bpm)</strong> &mdash; Patients with known prior or controlled AF who are hemodynamically stable during AF with a rapid ventricular response may be treated with calcium channel blockers or beta blockers to attempt to control HR, rather than immediate cardioversion, particularly if there is potential risk for a left atrial appendage thrombus that may be embolized during cardioversion. (See <a href=\"topic.htm?path=control-of-ventricular-rate-in-atrial-fibrillation-pharmacologic-therapy\" class=\"medical medical_review\">&quot;Control of ventricular rate in atrial fibrillation: Pharmacologic therapy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Nonrapid ventricular rate &lt;120 bpm</strong> &mdash; Patients who develop AF with a ventricular response &lt;120 bpm are often hemodynamically stable. Those who are at risk for developing ischemia or hemodynamic instability require control of the ventricular rate. An IV beta blocker (eg, bolus doses of <a href=\"topic.htm?path=esmolol-drug-information\" class=\"drug drug_general\">esmolol</a> 10 to 25 mg or <a href=\"topic.htm?path=metoprolol-drug-information\" class=\"drug drug_general\">metoprolol</a> 1 to 5 mg) may be administered to decrease HR to &le;80 bpm, provided that BP is adequate and there are no contraindications. Other agents employed to decrease HR include calcium channel blockers (eg, <a href=\"topic.htm?path=verapamil-drug-information\" class=\"drug drug_general\">verapamil</a> or <a href=\"topic.htm?path=diltiazem-drug-information\" class=\"drug drug_general\">diltiazem</a>) or <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a> (<a href=\"image.htm?imageKey=ANEST%2F110671\" class=\"graphic graphic_table graphicRef110671 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/9\" class=\"abstract_t\">9</a>]. Since both beta blockers and calcium channel blockers have negative inotropic effects, small incremental doses of these rate control medications are used in patients with left ventricular systolic failure. (See <a href=\"topic.htm?path=control-of-ventricular-rate-in-atrial-fibrillation-pharmacologic-therapy\" class=\"medical medical_review\">&quot;Control of ventricular rate in atrial fibrillation: Pharmacologic therapy&quot;</a>.)</p><p/><p>Details regarding further management of atrial fibrillation with antiarrhythmic medications are available in other topics. (See <a href=\"topic.htm?path=control-of-ventricular-rate-in-atrial-fibrillation-pharmacologic-therapy\" class=\"medical medical_review\">&quot;Control of ventricular rate in atrial fibrillation: Pharmacologic therapy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2466304913\"><span class=\"h3\">Atrial flutter</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Atrial flutter typically presents with a rapid ventricular rate (approximately 150 bpm) (<a href=\"image.htm?imageKey=CARD%2F74395\" class=\"graphic graphic_waveform graphicRef74395 \">waveform 6</a>). (See <a href=\"topic.htm?path=electrocardiographic-and-electrophysiologic-features-of-atrial-flutter\" class=\"medical medical_review\">&quot;Electrocardiographic and electrophysiologic features of atrial flutter&quot;</a>.) Intraoperative treatment is similar to that for AF. (See <a href=\"#H2381976445\" class=\"local\">'Atrial fibrillation'</a> above.)</p><p class=\"headingAnchor\" id=\"H3322910683\"><span class=\"h3\">Atrioventricular nodal reentrant tachycardia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>AV nodal reentrant tachycardia (AVNRT) is a paroxysmal SVT due to a reentry circuit around the AV node (<a href=\"image.htm?imageKey=CARD%2F57001\" class=\"graphic graphic_waveform graphicRef57001 \">waveform 7</a> and <a href=\"image.htm?imageKey=CARD%2F81639\" class=\"graphic graphic_waveform graphicRef81639 \">waveform 8</a>). Cardioversion should be attempted in a hemodynamically unstable patient who does not respond immediately to vagal maneuvers <span class=\"nowrap\">and/or</span> pharmacologic treatment with adenosine or a calcium channel blocker, medications that are usually available in the operating room (OR) or the OR pharmacy (<a href=\"image.htm?imageKey=ANEST%2F110671\" class=\"graphic graphic_table graphicRef110671 \">table 2</a>). (See <a href=\"topic.htm?path=atrioventricular-nodal-reentrant-tachycardia\" class=\"medical medical_review\">&quot;Atrioventricular nodal reentrant tachycardia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2498766903\"><span class=\"h3\">Multifocal atrial tachycardia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multifocal atrial tachycardia (MAT) is an uncommon arrhythmia that is usually associated with severe pulmonary disease. MAT presents with P waves of differing morphologies and a HR &gt;100 bpm (<a href=\"image.htm?imageKey=CARD%2F70173\" class=\"graphic graphic_waveform graphicRef70173 \">waveform 9</a>), typically with stable hemodynamics. However, a rapid ventricular response &gt;130 bpm may be associated with hypotension, particularly if the rapid HR causes myocardial ischemia in a patient with coronary artery disease. Pharmacologic agents may be administered to achieve rate control (eg, beta blockers or calcium channel blockers (<a href=\"image.htm?imageKey=ANEST%2F110671\" class=\"graphic graphic_table graphicRef110671 \">table 2</a>)), and any treatable underlying disorder should be addressed (eg, electrolyte abnormalities). (See <a href=\"topic.htm?path=multifocal-atrial-tachycardia\" class=\"medical medical_review\">&quot;Multifocal atrial tachycardia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3076912183\"><span class=\"h2\">Wide QRS complex atrial tachycardias</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute management of a patient with regular or irregular wide complex tachycardia (WCT) depends on whether the patient is hemodynamically stable. Hemodynamic compromise may occur with any WCT, regardless of etiology, but is more likely with ventricular tachycardia (VT) rather than a supraventricular arrhythmia. For hemodynamically unstable patients, prompt treatment with electrical <span class=\"nowrap\">cardioversion/defibrillation</span> is necessary to prevent further clinical deterioration or sudden cardiac arrest (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 1</a>). (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H16\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Regular wide complex'</a> and <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H17\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Irregular wide complex'</a>.)</p><p>For hemodynamically stable patients, additional time may be spent attempting to determine the diagnosis. If the initial diagnosis of WCT was made from a single-lead rhythm strip, a full 12-lead ECG may be useful because the presence of AV dissociation <span class=\"nowrap\">and/or</span> a QRS width &ge;0.16 is diagnostic of VT [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/10\" class=\"abstract_t\">10</a>]. However, in approximately 10 percent of patients with wide complex tachycardia, a definitive diagnosis of SVT versus VT is difficult to establish. Thus, expert consultation is recommended as soon as possible [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/6,11\" class=\"abstract_t\">6,11</a>]. Approaches to diagnosis and management of wide QRS complex tachycardias are discussed separately. (See <a href=\"topic.htm?path=approach-to-the-diagnosis-of-wide-qrs-complex-tachycardias\" class=\"medical medical_review\">&quot;Approach to the diagnosis of wide QRS complex tachycardias&quot;</a> and <a href=\"topic.htm?path=wide-qrs-complex-tachycardias-approach-to-management\" class=\"medical medical_review\">&quot;Wide QRS complex tachycardias: Approach to management&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H3107053684\"><span class=\"h3\">Supraventricular tachycardia with aberrant conduction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>SVT with aberrant conduction is monomorphic with a very regular RR interval. A trial of vagal maneuvers <span class=\"nowrap\">and/or</span> adenosine can provide both diagnostic information and may be therapeutic if the WCT resolves. A continuous rhythm strip should be obtained during any intervention that is intended to slow or terminate the SVT. (See <a href=\"topic.htm?path=wide-qrs-complex-tachycardias-approach-to-management#H172942951\" class=\"medical medical_review\">&quot;Wide QRS complex tachycardias: Approach to management&quot;, section on 'Vagal maneuvers'</a> and <a href=\"topic.htm?path=wide-qrs-complex-tachycardias-approach-to-management#H172942963\" class=\"medical medical_review\">&quot;Wide QRS complex tachycardias: Approach to management&quot;, section on 'Pharmacologic interventions'</a>.)</p><p>In a stable patient with WCT known to be supraventricular in origin, management is similar to that for narrow QRS complex SVTs (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 1</a>). (See <a href=\"topic.htm?path=wide-qrs-complex-tachycardias-approach-to-management#H528288449\" class=\"medical medical_review\">&quot;Wide QRS complex tachycardias: Approach to management&quot;, section on 'Supraventricular tachycardia'</a>.)</p><p class=\"headingAnchor\" id=\"H2262937916\"><span class=\"h3\">Wolff-Parkinson-White syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with classic preexcited atrial fibrillation (eg, Wolff-Parkinson-White [WPW] syndrome) have an AV reciprocating tachycardia (AVRT) due to a macroreentrant circuit. It is critical to know whether the AVRT is orthodromic (with antegrade conduction occurring via the AV node and retrograde conduction via an accessory pathway) or antidromic (with antegrade conduction occurring via the accessory pathway and retrograde conduction via the AV node [or sometimes via a second accessory pathway]), in order to choose the correct initial pharmacologic therapy if an intraoperative tachyarrhythmia occurs. Thus, preoperative consultation with an electrophysiology cardiologist is important to understand optimal treatment of potential tachyarrhythmias in a patient with known or suspected WPW syndrome. (See <a href=\"topic.htm?path=treatment-of-symptomatic-arrhythmias-associated-with-the-wolff-parkinson-white-syndrome#H9925775\" class=\"medical medical_review\">&quot;Treatment of symptomatic arrhythmias associated with the Wolff-Parkinson-White syndrome&quot;, section on 'Acute treatment of symptomatic arrhythmias'</a>.)</p><p>If an intraoperative tachycardia is associated with hemodynamic instability in a patient who has known or suspected WPW, treatment is immediate synchronized cardioversion, similar to treatment of SVT due to other etiologies (see <a href=\"#H1843426040\" class=\"local\">'Urgent management'</a> above).</p><p>For a hemodynamically stable patient, management depends on whether conduction is orthodromic or antidromic:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with orthodromic AVRT may have either a narrow or wide QRS complex. If the complex is narrow or the patient is known to have orthodromic AVRT, initial treatment is one or more vagal maneuvers (such as carotid sinus massage and the Valsalva maneuver). If vagal maneuvers are ineffective, adenosine or <a href=\"topic.htm?path=verapamil-drug-information\" class=\"drug drug_general\">verapamil</a> may be administered (<a href=\"image.htm?imageKey=ANEST%2F110671\" class=\"graphic graphic_table graphicRef110671 \">table 2</a>). (See <a href=\"topic.htm?path=treatment-of-symptomatic-arrhythmias-associated-with-the-wolff-parkinson-white-syndrome#H4\" class=\"medical medical_review\">&quot;Treatment of symptomatic arrhythmias associated with the Wolff-Parkinson-White syndrome&quot;, section on 'Acute termination of orthodromic AVRT'</a>.) &#160;</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with antidromic AVRT always have a wide QRS complex tachycardia [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/12\" class=\"abstract_t\">12</a>]. If the complex is wide, standard AV nodal blocking agents should NOT be administered (eg, beta blockers, non-dihydropyridine calcium channel blockers [<a href=\"topic.htm?path=verapamil-drug-information\" class=\"drug drug_general\">verapamil</a> and <a href=\"topic.htm?path=diltiazem-drug-information\" class=\"drug drug_general\">diltiazem</a>], <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>, adenosine, <a href=\"topic.htm?path=digoxin-drug-information\" class=\"drug drug_general\">digoxin</a>), because blocking the AV node may result in faster conduction of atrial impulses to the ventricle via the accessory pathway, with consequent increase in ventricular rate, exacerbation of hemodynamic instability, and potential for degeneration of the rhythm into lethal VT or ventricular fibrillation [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/13\" class=\"abstract_t\">13</a>]. </p><p/><p class=\"bulletIndent1\">Since it is often difficult to determine if a wide QRS complex tachyarrhythmia has antidromic or orthodromic conduction (and is definitely of supraventricular origin rather than VT), we typically treat wide QRS complex tachyarrhythmia with intravenous <a href=\"topic.htm?path=procainamide-drug-information\" class=\"drug drug_general\">procainamide</a> in a hemodynamically stable patient, in an effort to terminate the tachycardia, or at least slow the ventricular response. We also seek urgent consultation with an electrophysiology cardiologist. (See <a href=\"topic.htm?path=treatment-of-symptomatic-arrhythmias-associated-with-the-wolff-parkinson-white-syndrome#H7\" class=\"medical medical_review\">&quot;Treatment of symptomatic arrhythmias associated with the Wolff-Parkinson-White syndrome&quot;, section on 'Acute termination of antidromic AVRT'</a>.) &#160;</p><p/><p/><p class=\"headingAnchor\" id=\"H412752339\"><span class=\"h1\">VENTRICULAR ARRHYTHMIAS</span></p><p class=\"headingAnchor\" id=\"H100846285\"><span class=\"h2\">Emergency management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pulseless ventricular tachycardia (VT) and ventricular fibrillation (VF) should be treated immediately with defibrillation and advanced cardiac life support (ACLS), with repeated shocks as indicated (<a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 2</a>). During cardiopulmonary resuscitation (CPR), intravenous (IV) <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> 1 mg every three to five minutes is administered, as well as <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a> 300 mg for the first dose and 150 mg for the second and third doses. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H8\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Ventricular fibrillation and pulseless ventricular tachycardia'</a>.)</p><p>VT with a pulse may be treated with synchronized cardioversion (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 1</a>).<em> </em>(See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H16\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Regular wide complex'</a>.)</p><p>Possible causes of ventricular tachyarrhythmias should be investigated and treated, with particular attention to the &quot;H's (ie, hypoxia, hypovolemia, acidosis [hydrogen ion], hypo- or hyperkalemia, hypothermia) and T's&quot; (ie, tension pneumothorax, cardiac tamponade, toxins, pulmonary or coronary thrombosis) (see <a href=\"#H1841031312\" class=\"local\">'Contributing factors'</a> above) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H1290779637\"><span class=\"h2\">Ventricular fibrillation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ventricular fibrillation requires emergency initiation of cardiopulmonary resuscitation (CPR) and immediate defibrillation as the first steps of the ACLS algorithm (<a href=\"image.htm?imageKey=CARD%2F80454\" class=\"graphic graphic_waveform graphicRef80454 \">waveform 10</a> and <a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 2</a>). Subsequent treatment is described separately. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H8\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Ventricular fibrillation and pulseless ventricular tachycardia'</a>.)</p><p class=\"headingAnchor\" id=\"H2150709257\"><span class=\"h2\">Monomorphic ventricular tachycardia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A regular rhythm with a widened QRS complex may be monomorphic VT (<a href=\"image.htm?imageKey=CARD%2F63176\" class=\"graphic graphic_waveform graphicRef63176 \">waveform 11</a> and <a href=\"image.htm?imageKey=CARD%2F81690\" class=\"graphic graphic_waveform graphicRef81690 \">waveform 12</a>) or ventricular flutter (<a href=\"image.htm?imageKey=CARD%2F65800\" class=\"graphic graphic_waveform graphicRef65800 \">waveform 13</a>). Patients with VT or flutter typically present with hypotension with or without a pulse. Pulseless VT should be treated immediately with defibrillation and ACLS (<a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 2</a>), whereas VT with a pulse may be treated with synchronized cardioversion (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 1</a>).<em> </em>(See <a href=\"topic.htm?path=approach-to-the-diagnosis-of-wide-qrs-complex-tachycardias\" class=\"medical medical_review\">&quot;Approach to the diagnosis of wide QRS complex tachycardias&quot;</a>.)</p><p>If necessary, myocardial perfusion is augmented with infusion of a vasoconstrictor such as <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>, vasopressin, or norepinephrine (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 3</a>). <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">Epinephrine</a> is generally avoided due to possible exacerbation of myocardial ischemia, but if selected, the infusion should be titrated to effect to avoid tachycardia. If blood pressure is adequate, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a> or <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a> may be administered to reduce the frequency of VT. </p><p class=\"headingAnchor\" id=\"H2547867389\"><span class=\"h2\">Polymorphic ventricular tachycardia (torsades de pointes)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Torsades de pointes (TdP) is an irregular polymorphic ventricular tachycardia (<a href=\"image.htm?imageKey=CARD%2F53891\" class=\"graphic graphic_waveform graphicRef53891 \">waveform 14</a>). Prompt defibrillation is indicated if the patient is hemodynamically unstable. (See <a href=\"topic.htm?path=overview-of-the-acute-management-of-tachyarrhythmias#H16\" class=\"medical medical_review\">&quot;Overview of the acute management of tachyarrhythmias&quot;, section on 'Polymorphic ventricular tachycardia'</a>.)</p><p>First-line therapy in a stable patient having recurrent episodes of torsades de pointes in the perioperative period is administration of <a href=\"topic.htm?path=magnesium-sulfate-drug-information\" class=\"drug drug_general\">magnesium sulfate</a> 2 grams as a slow IV bolus. Temporary transvenous overdrive pacing (atrial or ventricular) at approximately 100 bpm is generally reserved for patients with TdP related to long QT syndrome who do not respond to intravenous magnesium.</p><p>If the rhythm degenerates into ventricular fibrillation, ACLS with CPR is initiated and immediate defibrillation is performed (<a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 2</a>). (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H17\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Irregular wide complex'</a>.)</p><p>Cardiology consultation is recommended as soon as possible. Additional details regarding acute management of TdP are discussed separately. </p><p class=\"headingAnchor\" id=\"H3641817214\"><span class=\"h3\">Prolonged QT interval: Perioperative medications that increase risk</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Certain agents that are commonly used during the perioperative period (eg, <a href=\"topic.htm?path=methadone-drug-information\" class=\"drug drug_general\">methadone</a>, <a href=\"topic.htm?path=droperidol-drug-information\" class=\"drug drug_general\">droperidol</a>, <a href=\"topic.htm?path=ondansetron-drug-information\" class=\"drug drug_general\">ondansetron</a>) may prolong the QT interval and increase risk for TdP and malignant ventricular arrhythmias, particularly if the patient has a previously prolonged QT interval, or if a large dose or more than one such agent is administered. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=methadone-drug-information\" class=\"drug drug_general\">Methadone</a> &mdash; Methadone administered in large doses prolongs the QT interval and has been linked with TdP [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/14,15\" class=\"abstract_t\">14,15</a>]. Patients receiving chronic methadone therapy should have a preoperative baseline electrocardiogram (ECG) before receiving any other perioperative medications that may further prolong the QT interval.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=droperidol-drug-information\" class=\"drug drug_general\">Droperidol</a> <strong>and </strong><a href=\"topic.htm?path=haloperidol-drug-information\" class=\"drug drug_general\">haloperidol</a> &mdash; Low doses of the butyrophenone antiemetic agents haloperidol and droperidol are used for prophylaxis or management of postoperative nausea and vomiting (PONV); however, these agents are associated with an increase in the QT interval and should be avoided in patients with preexisting QT prolongation [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/16,17\" class=\"abstract_t\">16,17</a>]. The US Food and Drug Administration (FDA) issued a boxed warning for droperidol regarding the potential for sudden cardiac death with its use. (See <a href=\"topic.htm?path=postoperative-nausea-and-vomiting#H2984798969\" class=\"medical medical_review\">&quot;Postoperative nausea and vomiting&quot;, section on 'Butyrophenones'</a>.) </p><p/><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=ondansetron-drug-information\" class=\"drug drug_general\">Ondansetron</a><strong> </strong>&mdash; The serotonin antagonists (ondansetron, <a href=\"topic.htm?path=granisetron-drug-information\" class=\"drug drug_general\">granisetron</a>, and, outside the United States, <a href=\"topic.htm?path=dolasetron-drug-information\" class=\"drug drug_general\">dolasetron</a>, ramosetron, and tropisetron) may prolong the QT interval and should be avoided in a patient with preexisting QT prolongation. (See <a href=\"topic.htm?path=postoperative-nausea-and-vomiting#H3622478147\" class=\"medical medical_review\">&quot;Postoperative nausea and vomiting&quot;, section on 'Serotonin (5-hydroxytryptamine) receptor antagonists'</a>.)</p><p/><p>Many anesthetic agents (eg, opioids, <a href=\"topic.htm?path=dexmedetomidine-drug-information\" class=\"drug drug_general\">dexmedetomidine</a>, <a href=\"topic.htm?path=midazolam-drug-information\" class=\"drug drug_general\">midazolam</a>, <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">etomidate</a>, <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a>, volatile anesthetic agents) may cause mild prolongation of the QT interval (&gt;440 ms), but are not likely to cause TdP (<a href=\"image.htm?imageKey=ANEST%2F110771\" class=\"graphic graphic_table graphicRef110771 \">table 4</a>) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/18-30\" class=\"abstract_t\">18-30</a>].</p><p class=\"headingAnchor\" id=\"H3424506429\"><span class=\"h2\">Nonsustained ventricular tachycardia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nonsustained ventricular tachycardia (NSVT) is diagnosed when three or more consecutive ventricular beats are noted on the ECG, at a rate &gt;120 beats per minute (bpm) that lasts less than 30 seconds (<a href=\"image.htm?imageKey=CARD%2F73299\" class=\"graphic graphic_waveform graphicRef73299 \">waveform 15</a>). (See <a href=\"topic.htm?path=nonsustained-ventricular-tachycardia-clinical-manifestations-evaluation-and-management\" class=\"medical medical_review\">&quot;Nonsustained ventricular tachycardia: Clinical manifestations, evaluation, and management&quot;</a>.)</p><p>Patients with NSVT without hemodynamic compromise should be continuously monitored during both the intraoperative and postoperative periods since degeneration into a nonperfusing rhythm (eg, VT or VF) may occur. If heart rate (HR) is &gt;100 bpm and the patient does not have compromised cardiac function or hypotension, a beta blocker or calcium channel blocker may be administered to reduce the ventricular rate (<a href=\"image.htm?imageKey=ANEST%2F110671\" class=\"graphic graphic_table graphicRef110671 \">table 2</a>). <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">Amiodarone</a> or class IB agents (eg, <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a>) may also be effective to maintain sinus rhythm. Similar to patients with PVCs, electrolyte abnormalities and myocardial ischemia should be suspected and treated. </p><p>Further management with antiarrhythmic medications is discussed separately. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H319624669\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Treatment of ischemia'</a> and <a href=\"topic.htm?path=role-of-antiarrhythmic-drugs-for-ventricular-arrhythmias-in-patients-with-a-prior-myocardial-infarction\" class=\"medical medical_review\">&quot;Role of antiarrhythmic drugs for ventricular arrhythmias in patients with a prior myocardial infarction&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H875200345\"><span class=\"h2\">Premature ventricular contractions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Premature ventricular contractions (PVCs) are common in the general population, even in patients without cardiac disease (<a href=\"image.htm?imageKey=CARD%2F57511\" class=\"graphic graphic_waveform graphicRef57511 \">waveform 16</a>). Isolated PVCs are usually clinically insignificant, particularly if they occur in a healthy surgical patient due to increased sympathetic stimulation. (See <a href=\"topic.htm?path=ventricular-premature-beats\" class=\"medical medical_review\">&quot;Ventricular premature beats&quot;</a>.)</p><p>The presence of PVCs may be a sign of myocardial ischemia or electrolyte abnormalities (see <a href=\"#H1841031312\" class=\"local\">'Contributing factors'</a> above). These conditions should be suspected as contributing factors and treated if confirmed, particularly in patients with pre-existing cardiac conditions such as hypertension, ischemic heart disease, systolic or diastolic heart failure, or hypertrophic cardiomyopathy.</p><p class=\"headingAnchor\" id=\"H1913350269\"><span class=\"h2\">Ventricular paced rhythms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the setting of a supraventricular tachycardia (SVT) in a patient with a pacemaker, the pacemaker may &quot;track&quot; the atrial rate and pace the ventricle with the same rate. This may appear similar to VT on the electrocardiogram (ECG), particularly if the rate is rapid (<a href=\"image.htm?imageKey=CARD%2F64812\" class=\"graphic graphic_waveform graphicRef64812 \">waveform 17</a>). It is also possible for a pacemaker to cause retrograde conduction that passes from the ventricle to the atrium, and then conducts again to the ventricle, resulting in an endless loop tachycardia with a wide QRS complex. </p><p>To achieve a normal ventricular rate, it may be necessary to reset the pacemaker to an asynchronous mode (at a lower rate) by employing a magnet or a programming machine. (See <a href=\"topic.htm?path=perioperative-management-of-patients-with-a-pacemaker-or-implantable-cardioverter-defibrillator#H3791148210\" class=\"medical medical_review\">&quot;Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator&quot;, section on 'Reprogramming with a programming machine'</a> and <a href=\"topic.htm?path=perioperative-management-of-patients-with-a-pacemaker-or-implantable-cardioverter-defibrillator#H1373117221\" class=\"medical medical_review\">&quot;Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator&quot;, section on 'Magnet application'</a>.) </p><p class=\"headingAnchor\" id=\"H1803355460\"><span class=\"h1\">BRADYARRHYTHMIAS</span></p><p class=\"headingAnchor\" id=\"H3749139260\"><span class=\"h2\">Urgent management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bradycardia is treated with an anticholinergic agent <span class=\"nowrap\">and/or</span> chronotropic agents if it is severe (eg, heart rate [HR] &lt;40 beats per minute [bpm] or associated with transient episodes of asystole), or if there are signs of inadequate perfusion (eg, hypotension or electrocardiographic evidence of ischemia). In some cases, temporary pacing may be necessary. If neither pharmacologic therapy nor initial transcutaneous pacing is effective, preparations are made for transvenous pacing while urgent cardiology consultation is obtained to evaluate the patient for permanent pacemaker placement. (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H11\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Bradycardia'</a>.)</p><p>If a severe bradyarrhythmia deteriorates into asystole, immediate cardiopulmonary resuscitation (CPR) and advanced cardiac life support (ACLS) is necessary (<a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 2</a>). (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H9\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Asystole and pulseless electrical activity'</a>.)</p><p class=\"headingAnchor\" id=\"H1600607570\"><span class=\"h3\">Pharmacologic agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intravenous (IV) <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a> 0.5 mg is the first line of therapy for treatment of bradycardia; it may be repeated every three to five minutes up to a total of 3 mg (<a href=\"image.htm?imageKey=EM%2F63919\" class=\"graphic graphic_algorithm graphicRef63919 \">algorithm 3</a>). For persistent severe bradycardia, positive chronotropic agents may be administered to increase HR (eg, <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a>, dopamine, <a href=\"topic.htm?path=dobutamine-drug-information\" class=\"drug drug_general\">dobutamine</a>, <a href=\"topic.htm?path=isoproterenol-drug-information\" class=\"drug drug_general\">isoproterenol</a>) (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 3</a>). </p><p class=\"headingAnchor\" id=\"H2806807069\"><span class=\"h3\">Temporary pacing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In some cases, temporary pacing may be necessary to achieve and maintain hemodynamic stability, although pacing is rarely indicated in a hemodynamically stable patient with an HR of 40 to 60 bpm. Temporary pacing during the perioperative period may be accomplished using a transcutaneous, transvenous, pulmonary artery catheter (PAC), or transesophageal pacing modality. (See <a href=\"topic.htm?path=temporary-cardiac-pacing\" class=\"medical medical_review\">&quot;Temporary cardiac pacing&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1096910346\"><span class=\"h4\">Transcutaneous pacing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transcutaneous pacing is typically the most rapid way to correct bradycardia, especially during surgery with general anesthesia. (See <a href=\"topic.htm?path=perioperative-management-of-patients-with-a-pacemaker-or-implantable-cardioverter-defibrillator#H2081099542\" class=\"medical medical_review\">&quot;Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator&quot;, section on 'Placement of transcutaneous pacing/defibrillator pads'</a>.)</p><p>Transcutaneous pads should be placed to the right of the sternum immediately below the clavicle and at the left ventricular apex, usually at the fifth or sixth intercostal space in the midaxillary line, although anterior-posterior pad positioning is an alternative for selected surgical procedures (<a href=\"image.htm?imageKey=CARD%2F103268\" class=\"graphic graphic_figure graphicRef103268 \">figure 1</a>). The pacing mode of an external defibrillator with pacing capability is activated, and the pacing current is increased up to 65 to 100 milliamperes until a stable HR is achieved. Appropriate pacing capture of the myocardium typically results in increased cardiac output and stabilization of hemodynamics. Notably, for patients who are awake or only mildly sedated (eg, monitored anesthesia care [MAC]), transcutaneous pacing may be painful, necessitating a deeper level of sedation or anesthesia during transcutaneous pacing. (See <a href=\"topic.htm?path=temporary-cardiac-pacing#H13078059\" class=\"medical medical_review\">&quot;Temporary cardiac pacing&quot;, section on 'Transcutaneous'</a>.)</p><p>Pacing capture may be difficult to achieve in a morbidly obese patient or when appropriate pad placement is not possible (eg, thoracic surgery, lateral or prone position, extensive burns, excessive hair). In such cases, alternative methods are employed. (See <a href=\"#H522983336\" class=\"local\">'Transvenous pacing'</a> below and <a href=\"#H1410735157\" class=\"local\">'Pacing pulmonary artery catheters'</a> below and <a href=\"#H1170835862\" class=\"local\">'Transesophageal pacing'</a> below.)</p><p class=\"headingAnchor\" id=\"H522983336\"><span class=\"h4\">Transvenous pacing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intraoperative transvenous pacing may be used if transcutaneous pacing fails to reliably capture the myocardium or is not feasible due to the location of the surgical procedure. Transvenous pacing requires insertion of an introducer sheath in a central vessel, most commonly the right internal jugular vein. This may be impractical once a surgical case is underway, depending on the type of surgery and prior positioning of the patient and configuration of the sterile surgical drapes. Transvenous pacing is contraindicated in a patient with a mechanical prosthetic tricuspid valve because the pacemaker lead could damage or become trapped within the valve. (See <a href=\"topic.htm?path=temporary-cardiac-pacing#H410648640\" class=\"medical medical_review\">&quot;Temporary cardiac pacing&quot;, section on 'Transvenous'</a>.)</p><p>Insertion of the pacing lead requires continuous electrocardiographic (ECG) monitoring due to a high risk for inducing arrhythmias. Correct placement requires expertise in both transvenous wire insertion and pacing technology; thus, cardiology consultation may be required. Ideally, use of fluoroscopy with direct visualization of the pacing lead during insertion will ensure optimal placement within the right ventricle. If intraoperative fluoroscopy is not possible, a postoperative radiograph is necessary to check correct positioning. (See <a href=\"topic.htm?path=temporary-cardiac-pacing#H13078080\" class=\"medical medical_review\">&quot;Temporary cardiac pacing&quot;, section on 'Procedural aspects of temporary transvenous pacing'</a>.)</p><p class=\"headingAnchor\" id=\"H1410735157\"><span class=\"h4\">Pacing pulmonary artery catheters</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Specialized pulmonary artery catheters (PACs) with pacing capability can be used with an external pacemaker. In contrast to a transvenous pacing wire, anesthesiologists are typically familiar with positioning a pacing PAC by employing pressure waveform analysis during insertion. Catheter position can be confirmed with intraoperative transesophageal echocardiography (TEE) <span class=\"nowrap\">and/or</span> a postoperative radiograph. However, the leads within a pacing PAC are typically less stable than those of a dedicated transvenous pacing wire. Other disadvantages of a pacing PAC are similar to a transvenous pacing lead (eg, challenges with placement of an introducer sheath in a central vein, contraindication with a mechanical tricuspid valve). &#160;</p><p class=\"headingAnchor\" id=\"H1170835862\"><span class=\"h4\">Transesophageal pacing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A transesophageal pacing probe can be placed via the mouth or nose to rest in the esophagus directly behind the left atrium. However, atrial capture and consistent pacing depends on careful positioning of the probe and is often unreliable. Also, ventricular pacing is not usually possible; thus, if complete heart block is present, transesophageal atrial pacing will not restore an adequate HR. For these reasons, this modality is used only when other options are unavailable or have failed. </p><p class=\"headingAnchor\" id=\"H3843570580\"><span class=\"h2\">Sinus bradycardia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sinus bradycardia occurs when there is normal atrial and ventricular depolarization, but the heart rate (HR) is &lt;60 bpm (<a href=\"image.htm?imageKey=CARD%2F52675\" class=\"graphic graphic_waveform graphicRef52675 \">waveform 18</a>). Mild sinus bradycardia (ie, HR 40 to 60 bpm) that remains stable in an asymptomatic patient does not require treatment. Sinus bradycardia that is more severe bradycardia or associated with hemodynamic instability is treated as outlined above (see <a href=\"#H3749139260\" class=\"local\">'Urgent management'</a> above).</p><p>When sinus bradycardia is associated with vagal reflexes, neuraxial anesthesia, or medications, alternative or additional treatment may be necessary, as outlined below.</p><p class=\"headingAnchor\" id=\"H2224933693\"><span class=\"h3\">Vagal reflexes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Surgical manipulation may precipitate vagal reflexes that cause bradycardia. For example, the oculocardiac reflex occurs when traction of the extraocular muscles activates a parasympathetic response via the ophthalmic branch of the trigeminal nerve. This reflex may cause severe bradycardia and even asystole. Another example is peritoneal stretching during open or laparoscopic abdominal surgery, which may cause a parasympathetically mediated bradycardia. In such cases, the surgeon should immediately cease manipulation.</p><p>If HR does not immediately increase after cessation of surgical manipulation, an anticholinergic agent is administered. In this situation, <a href=\"topic.htm?path=glycopyrrolate-glycopyrronium-drug-information\" class=\"drug drug_general\">glycopyrrolate</a> in 0.2 mg increments up to 1 mg is often selected rather than <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a>, particularly in patients with ischemic heart disease. However, small incremental doses of atropine 0.2 mg may be administered with attention to avoiding undesirable tachycardia that may lead to myocardial ischemia or central anticholinergic syndrome in an elderly patient. </p><p class=\"headingAnchor\" id=\"H1292176759\"><span class=\"h3\">Neuraxial anesthesia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neuraxial anesthesia with a T1 to T4 anesthetic level may cause sinus bradycardia and hypotension [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/31-34\" class=\"abstract_t\">31-34</a>]. Although <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a> may be administered, bradycardia caused by blockade of the cardiac accelerator fibers responds best to beta-adrenergic agonists such as <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a> 5 to 10 mg or <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> 10 to 20 mcg, followed by an epinephrine infusion for persistent bradycardia (<a href=\"image.htm?imageKey=PULM%2F99963\" class=\"graphic graphic_table graphicRef99963 \">table 5</a>). If an epidural infusion is being delivered, it should be temporarily discontinued.</p><p>Notably, severe bradycardia or asystole associated with hypotension may suddenly occur after spinal anesthesia in an otherwise healthy individual. Onset is often unexpected since there may be a delay between administration of the spinal anesthetic and occurrence of such severe cardiovascular depression. This phenomenon has been termed vasovagal syncope, the Bezold-Jarisch reflex, and neurocardiogenic syncope. Immediate treatment with incrementally increased doses of <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> (eg, initial bolus of 10 to 20 mcg, then 100 mcg, then a larger bolus dose of 0.5 to 1.0 mg if there is minimal response) is necessary to avoid cardiac arrest that may result in serious patient injury or death [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/33-35\" class=\"abstract_t\">33-35</a>]. </p><p class=\"headingAnchor\" id=\"H3321066379\"><span class=\"h3\">Medications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following medications are potential causes of severe bradycardia that may require additional therapy:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Negative chronotropic agents</strong> &ndash; A beta blocker or other negative chronotropic agent (eg, calcium channel blockers, <a href=\"topic.htm?path=digoxin-drug-information\" class=\"drug drug_general\">digoxin</a>, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>) is the most common cause of sinus bradycardia. Patients with ischemic heart disease are often taking these drugs chronically, or they may be administered during the perioperative period to maintain HR in the range of 50 to 80 bpm. Baseline (admission) HR is noted, and bradycardia is treated only if it is severe (eg, HR &lt;40 bpm or associated with transient periods of asystole) or if there are signs of inadequate perfusion. (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H213850611\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Prevention of ischemia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Anticholinesterase agents </strong>&ndash; Sinus bradycardia may be caused by the muscarinic effects of an acetylcholinesterase inhibitor (eg, <a href=\"topic.htm?path=neostigmine-drug-information\" class=\"drug drug_general\">neostigmine</a> or <a href=\"topic.htm?path=edrophonium-drug-information\" class=\"drug drug_general\">edrophonium</a>) used for reversal of nondepolarizing neuromuscular blocking agents (NMBAs) near the end of surgery. The patient should receive an adequate dose of anticholinergic agent (eg, <a href=\"topic.htm?path=glycopyrrolate-glycopyrronium-drug-information\" class=\"drug drug_general\">glycopyrrolate</a> or <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a>) at the time the acetylcholinesterase inhibitor is administered. If underdosing of the anticholinergic agent (relative to the acetylcholinesterase inhibitor agent) is suspected, administration of an additional IV dose of glycopyrrolate 0.2 mg or atropine 0.4 mg is appropriate, and may be repeated. (See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Opioids</strong> &ndash; Severe bradycardia may occur when a large bolus dose of an opioid agent is administered (eg, <a href=\"topic.htm?path=sufentanil-drug-information\" class=\"drug drug_general\">sufentanil</a>, <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a>, <a href=\"topic.htm?path=remifentanil-drug-information\" class=\"drug drug_general\">remifentanil</a>) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/36-41\" class=\"abstract_t\">36-41</a>]. Treatment with a beta-adrenergic agonist (eg, <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a> 5 to 10 mg) or anticholinergic agent (eg, <a href=\"topic.htm?path=glycopyrrolate-glycopyrronium-drug-information\" class=\"drug drug_general\">glycopyrrolate</a> in 0.2 mg increments up to 1 mg or small incremental doses of <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a> 0.2 mg) will typically restore adequate HR.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Vasoconstrictors</strong> &ndash; The reflex response to hypertension caused by administration of a large dose of a vasoconstrictor (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>) may cause bradycardia. This effect is transient and typically responds to deepening the level of anesthesia. </p><p/><p class=\"headingAnchor\" id=\"H2280974143\"><span class=\"h2\">Sick sinus syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sick sinus syndrome is characterized by sinoatrial (SA) node dysfunction that may result in profound sinus bradycardia, sinus pauses, sinus arrest, and SA nodal exit block. (See <a href=\"topic.htm?path=sick-sinus-syndrome-clinical-manifestations-diagnosis-and-evaluation\" class=\"medical medical_review\">&quot;Sick sinus syndrome: Clinical manifestations, diagnosis, and evaluation&quot;</a> and <a href=\"topic.htm?path=sick-sinus-syndrome-treatment#H1\" class=\"medical medical_review\">&quot;Sick sinus syndrome: Treatment&quot;, section on 'Introduction'</a>.) </p><p>Temporary pacing may be required for patients with recurrent severe bradycardia and hemodynamic instability (see <a href=\"#H2806807069\" class=\"local\">'Temporary pacing'</a> above).</p><p class=\"headingAnchor\" id=\"H3389975165\"><span class=\"h2\">Bundle branch blocks</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Either a left bundle branch block (LBBB; (<a href=\"image.htm?imageKey=CARD%2F61594\" class=\"graphic graphic_waveform graphicRef61594 \">waveform 19</a>)), right bundle branch block (RBBB; (<a href=\"image.htm?imageKey=CARD%2F64393\" class=\"graphic graphic_waveform graphicRef64393 \">waveform 20</a>)), or fascicular block (<a href=\"image.htm?imageKey=CARD%2F115972\" class=\"graphic graphic_waveform graphicRef115972 \">waveform 21</a> and <a href=\"image.htm?imageKey=CARD%2F116957\" class=\"graphic graphic_waveform graphicRef116957 \">waveform 22</a>) can occur during anesthesia. New onset of such blocks usually indicates either intrinsic cardiac disease or myocardial ischemia, which should be rapidly addressed. Transient RBBB occasionally occurs during insertion of a PAC, which may lead to complete heart block in a patient with a preexisting LBBB. For this reason, transcutaneous pacing pads should be positioned on a patient with LBBB before PAC insertion.</p><p>Further treatment is discussed in separate topics:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=left-bundle-branch-block\" class=\"medical medical_review\">&quot;Left bundle branch block&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=right-bundle-branch-block\" class=\"medical medical_review\">&quot;Right bundle branch block&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=left-anterior-fascicular-block\" class=\"medical medical_review\">&quot;Left anterior fascicular block&quot;</a>.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=left-posterior-fascicular-block\" class=\"medical medical_review\">&quot;Left posterior fascicular block&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1720547143\"><span class=\"h2\">Conduction defects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>New onset of perioperative atrioventricular (AV) block typically occurs in the setting of intrinsic cardiac disease, perioperative ischemia, electrolyte abnormalities, excessive vagal tone, or iatrogenic causes (eg, surgical or transcatheter aortic valve replacement).</p><p>AV block is classified as first, second, or third degree:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>First degree AV block occurs when there is delayed but intact conduction from the atria to the ventricles (<a href=\"image.htm?imageKey=CARD%2F67882\" class=\"graphic graphic_waveform graphicRef67882 \">waveform 23</a>), and does not require treatment. (See <a href=\"topic.htm?path=first-degree-atrioventricular-block\" class=\"medical medical_review\">&quot;First degree atrioventricular block&quot;</a>.).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Second degree AV block occurs when there is intermittent conduction from the atria to the ventricles, with either progressive prolongation of the PR interval until there is a dropped ventricular beat (Type I [Wenckebach]; (<a href=\"image.htm?imageKey=CARD%2F73051\" class=\"graphic graphic_waveform graphicRef73051 \">waveform 24</a>)), or prolonged PR intervals with occasional dropped ventricular beats (Type II; (<a href=\"image.htm?imageKey=CARD%2F79539\" class=\"graphic graphic_waveform graphicRef79539 \">waveform 25</a> and <a href=\"image.htm?imageKey=CARD%2F58649\" class=\"graphic graphic_waveform graphicRef58649 \">waveform 26</a>)). Perioperative patients with second degree AV block may require pacing if bradycardia is severe <span class=\"nowrap\">and/or</span> causing hemodynamic compromise. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Third degree AV block occurs when atrial impulses do not conduct to the ventricles so that P waves are discordant with QRS waves (<a href=\"image.htm?imageKey=CARD%2F72863\" class=\"graphic graphic_waveform graphicRef72863 \">waveform 27</a>). Patients with third degree AV block typically require pacing since the intrinsic ventricular rhythm is usually very slow (approximately 30 to 40 bpm). (See <a href=\"topic.htm?path=third-degree-complete-atrioventricular-block\" class=\"medical medical_review\">&quot;Third degree (complete) atrioventricular block&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H3480950092\"><span class=\"h2\">Asystole</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients who develop severe bradycardia intraoperatively are at risk for progression to asystole or pulseless electrical activity, necessitating immediate initiation of ACLS (<a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 2</a>). (See <a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults#H9\" class=\"medical medical_review\">&quot;Advanced cardiac life support (ACLS) in adults&quot;, section on 'Asystole and pulseless electrical activity'</a>.)</p><p>Potentially reversible causes are similar to those for ventricular arrhythmias causing cardiac arrest (see <a href=\"#H1841031312\" class=\"local\">'Contributing factors'</a> above) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H1088736258\"><span class=\"h1\">SPECIAL PERIOPERATIVE SITUATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both atrial and ventricular arrhythmias are more likely during certain types of surgical procedures or other interventions.</p><p class=\"headingAnchor\" id=\"H2876333685\"><span class=\"h2\">Intrathoracic procedures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>During thoracic surgical procedures performed near the heart (eg, pulmonary or esophageal surgery), unintentional contact with cardiac or pulmonary venous structures may cause atrial or ventricular arrhythmias. </p><p>Surgical manipulation of the heart during cardiac surgical procedures causes myocardial irritability that may precipitate arrhythmias. (See <a href=\"topic.htm?path=cardiopulmonary-bypass-management#H1469252025\" class=\"medical medical_review\">&quot;Cardiopulmonary bypass: Management&quot;, section on 'Arrhythmias'</a>.)</p><p class=\"headingAnchor\" id=\"H3347731549\"><span class=\"h2\">Intravascular interventions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Transient atrial or ventricular arrhythmias commonly occur during insertion of a central venous catheter (CVC) or pulmonary artery catheter (PAC) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/42\" class=\"abstract_t\">42</a>]. For this reason, the electrocardiogram (ECG) is continuously monitored during these procedures. When the guidewire or catheter enters the right atrium, premature atrial contractions (PACs), atrial fibrillation (AF), or other supraventricular tachycardias (SVTs) may occur. Upon entry into the right ventricle, right bundle branch block (RBBB) [<a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/43\" class=\"abstract_t\">43</a>], premature ventricular contractions (PVCs), or ventricular tachycardia (VT) may occur. </p><p>Other intravascular interventions performed by surgeons or other interventionalists (eg, cardiac catheterization, endovascular revascularization) often cause atrial <span class=\"nowrap\">and/or</span> ventricular arrhythmias. (See <a href=\"topic.htm?path=anesthetic-considerations-for-electrophysiology-interventional-cardiology-and-transesophageal-echocardiography-procedures\" class=\"medical medical_review\">&quot;Anesthetic considerations for electrophysiology, interventional cardiology, and transesophageal echocardiography procedures&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H2226791375\"><span class=\"h2\">Local anesthetic toxicity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Local anesthetic systemic toxicity (LAST) should be suspected whenever physiologic changes occur after administration of local anesthetic. Cardiovascular (CV) signs usually occur simultaneously with or shortly after central nervous system (CNS) symptoms. These typically include tachycardia and hypertension, although bradycardia and hypotension have also been described as the first changes. CV toxicity can progress to ventricular arrhythmias <span class=\"nowrap\">and/or</span> asystole. Prevention and management of LAST are described separately (<a href=\"image.htm?imageKey=ANEST%2F107887\" class=\"graphic graphic_table graphicRef107887 \">table 6</a>). (See <a href=\"topic.htm?path=local-anesthetic-systemic-toxicity\" class=\"medical medical_review\">&quot;Local anesthetic systemic toxicity&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1299032942\"><span class=\"h2\">Electroconvulsive therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anesthesia for electroconvulsive therapy (ECT) is associated with various arrhythmias. (See <a href=\"topic.htm?path=technique-for-performing-electroconvulsive-therapy-ect-in-adults#H10\" class=\"medical medical_review\">&quot;Technique for performing electroconvulsive therapy (ECT) in adults&quot;, section on 'Anesthesia technique'</a>.) </p><p class=\"headingAnchor\" id=\"H3216529387\"><span class=\"h1\">POSTOPERATIVE MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The electrocardiogram (ECG) should be continuously monitored in the postanesthesia recovery unit (PACU) in any patient who developed an arrhythmia during anesthesia and surgery. Due to the possibility of underlying cardiac disease, a cardiology consultation should be obtained if the patient has recurrent or persistent arrhythmias. Postoperative assessment by a cardiologist is particularly important for patients with new onset of atrial fibrillation (AF), second or third degree atrioventricular (AV) block, or ventricular tachycardia (VT), as well as for any patient who required significant antiarrhythmia treatment, such as cardioversion, defibrillation, vasopressor support, or infusion of an antiarrhythmic agent.</p><p>Patients who had self-limited arrhythmias such as sinus tachycardia, sinus bradycardia, first degree AV block, AV nodal reentrant tachycardia (AVNRT), or premature ventricular contractions (PVCs) may not need a postoperative cardiology consultation, particularly if they did not require treatment for hemodynamic instability. In most of these cases, inciting causes are easily corrected and have often resolved by the time the patient arrives in the PACU.</p><p class=\"headingAnchor\" id=\"H1116023503\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-arrhythmias-in-adults\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Arrhythmias in adults&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-basic-and-advanced-cardiac-life-support-in-adults\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Basic and advanced cardiac life support in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H754484273\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If a perioperative arrhythmia cannot be readily diagnosed, all available leads are displayed on the monitor, and a 12-lead ECG is obtained. Notably, artifact due to electrocautery or pacing spikes can mimic ventricular tachycardia (VT) or ventricular fibrillation (VF), and ventricular-paced rhythms also mimic VT. Stable waveforms from the pulse oximeter, intra-arterial catheter, <span class=\"nowrap\">and/or</span> central venous catheter may be helpful to distinguish artifact from a true arrhythmia. (See <a href=\"#H3806099833\" class=\"local\">'Intraoperative diagnosis of arrhythmias'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Both atrial and ventricular arrhythmias are more likely to occur in the presence of myocardial ischemia or respiratory, metabolic, or electrolyte abnormalities, and during certain interventions (eg, intrathoracic surgery, intravascular interventions, electroconvulsive [ECT] therapy). (See <a href=\"#H1841031312\" class=\"local\">'Contributing factors'</a> above and <a href=\"#H1088736258\" class=\"local\">'Special perioperative situations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Atrial tachyarrhythmias with a heart rate (HR) &gt;100 beats per minute (bpm) may have a narrow QRS complex (QRS duration of &lt;120 ms) or a wide QRS complex (QRS duration &gt;120 ms).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Narrow QRS complex atrial tachyarrhythmias include sinus tachycardia, atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentrant tachycardia (AVNRT), and multifocal atrial tachycardia. (See <a href=\"#H584733046\" class=\"local\">'Narrow QRS complex atrial tachycardias'</a> above and <a href=\"#H3076912183\" class=\"local\">'Wide QRS complex atrial tachycardias'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Wide QRS complex atrial tachyarrhythmias include supraventricular tachycardia with aberrant conduction and Wolff-Parkinson-White (WPW) syndrome. Management of wide QRS complex atrial tachycardia is similar to that for narrow QRS complex tachyarrhythmias in most cases (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 1</a>). Expert cardiology consultation is recommended as soon as possible. (See <a href=\"#H3076912183\" class=\"local\">'Wide QRS complex atrial tachycardias'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment for narrow or wide QRS atrial tachyarrhythmias depends upon hemodynamic stability and the specific rhythm (<a href=\"image.htm?imageKey=EM%2F62714\" class=\"graphic graphic_algorithm graphicRef62714 \">algorithm 1</a>) (see <a href=\"#H1843426040\" class=\"local\">'Urgent management'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For hemodynamically unstable patients (eg, hypotension, myocardial ischemia, pulmonary edema), treatment is urgent cardioversion, unless the rhythm is sinus tachycardia. </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For hemodynamically stable patients, most atrial tachyarrhythmias are treated with intravenous (IV) pharmacologic therapy to control HR (eg, beta blockers, calcium channel blockers, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>) (<a href=\"image.htm?imageKey=ANEST%2F110671\" class=\"graphic graphic_table graphicRef110671 \">table 2</a>).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For hemodynamically stable patients with suspected WPW syndrome, standard atrioventricular (AV) nodal blocking agents (ie, beta blockers, calcium channel blockers, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>, adenosine, <a href=\"topic.htm?path=digoxin-drug-information\" class=\"drug drug_general\">digoxin</a>) should not be administered unless it is known whether orthodromic conduction is occurring through the AV node or antidromic conduction is occurring via an accessory pathway. With antidromic conduction, blocking the AV node may result in faster conduction of atrial impulses to the ventricle, increased ventricular rate, exacerbation of hemodynamic instability, and possible rhythm degeneration into VT or VF. If it is difficult to determine whether an arrhythmia is supraventricular with conduction via an accessory pathway rather than VT, and whether supraventricular conduction is orthodromic or antidromic, we typically treat with IV <a href=\"topic.htm?path=procainamide-drug-information\" class=\"drug drug_general\">procainamide</a> to terminate the tachycardia or slow the ventricular response. (See <a href=\"#H2262937916\" class=\"local\">'Wolff-Parkinson-White syndrome'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ventricular rhythms have a widened QRS complex (&gt;120 ms). These include ventricular-paced rhythms and ventricular tachyarrhythmias (eg, frequent premature ventricular contractions [PVCs], nonsustained VT, monomorphic VT, polymorphic VT such as torsades de pointes [TdP], VF). (See <a href=\"#H412752339\" class=\"local\">'Ventricular arrhythmias'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment for pulseless VT and VF is immediate defibrillation and advanced cardiac life support (ACLS), with repeated shocks as indicated (<a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 2</a>). VT with a pulse may be treated with synchronized cardioversion. Possible causes of ventricular tachyarrhythmias are investigated and treated. (See <a href=\"#H100846285\" class=\"local\">'Emergency management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bradyarrhythmias (heart rate [HR] &lt;40 beats per minute [bpm]) that occur during anesthesia include sinus bradycardia, sick sinus syndrome, bundle branch blocks, and conduction defects. Treatment includes (<a href=\"image.htm?imageKey=EM%2F63919\" class=\"graphic graphic_algorithm graphicRef63919 \">algorithm 3</a>) (see <a href=\"#H3749139260\" class=\"local\">'Urgent management'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>IV <a href=\"topic.htm?path=atropine-drug-information\" class=\"drug drug_general\">atropine</a> 0.5 mg, repeated every three to five minutes up to a total of 3 mg. If severe bradycardia persists, positive chronotropic agents (eg, <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a>, dopamine, <a href=\"topic.htm?path=dobutamine-drug-information\" class=\"drug drug_general\">dobutamine</a>, <a href=\"topic.htm?path=isoproterenol-drug-information\" class=\"drug drug_general\">isoproterenol</a>) may be administered to increase HR (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 3</a>). (See <a href=\"#H1600607570\" class=\"local\">'Pharmacologic agents'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In some cases, temporary pacing (eg, transcutaneous, transvenous, pacing pulmonary artery catheter, transesophageal modalities) may be necessary to achieve and maintain hemodynamic stability. (See <a href=\"#H2806807069\" class=\"local\">'Temporary pacing'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Treatment of causes (eg, surgical manipulation precipitating vagal reflexes, neuraxial anesthesia with a T1 to T4 anesthetic level, medications such as anticholinesterase agents, negative chronotropic agents, opioids, negative chronotropic agents, or vasoconstrictors). (See <a href=\"#H3843570580\" class=\"local\">'Sinus bradycardia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with asystole require immediate initiation of ACLS (<a href=\"image.htm?imageKey=EM%2F73862\" class=\"graphic graphic_algorithm graphicRef73862 \">algorithm 2</a>). (See <a href=\"#H3480950092\" class=\"local\">'Asystole'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the post-anesthesia care unit (PACU), the ECG is continuously monitored in patients who developed significant intraoperative arrhythmias, and a cardiology consultation is obtained if arrhythmias are recurrent or persistent. (See <a href=\"#H3216529387\" class=\"local\">'Postoperative management'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/1\" class=\"nounderline abstract_t\">Forrest JB, Cahalan MK, Rehder K, et al. Multicenter study of general anesthesia. II. Results. Anesthesiology 1990; 72:262.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/2\" class=\"nounderline abstract_t\">Forrest JB, Rehder K, Cahalan MK, Goldsmith CH. Multicenter study of general anesthesia. III. Predictors of severe perioperative adverse outcomes. Anesthesiology 1992; 76:3.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/3\" class=\"nounderline abstract_t\">London MJ, Hollenberg M, Wong MG, et al. Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography. Anesthesiology 1988; 69:232.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/4\" class=\"nounderline abstract_t\">Mattu A, Brady WJ, Robinson DA. Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med 2000; 18:721.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/5\" class=\"nounderline abstract_t\">Khan AM, Lubitz SA, Sullivan LM, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2013; 127:33.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/6\" class=\"nounderline abstract_t\">Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015; 132:S444.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/7\" class=\"nounderline abstract_t\">Bhave PD, Goldman LE, Vittinghoff E, et al. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J 2012; 164:918.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/8\" class=\"nounderline abstract_t\">Danelich IM, Lose JM, Wright SS, et al. Practical management of postoperative atrial fibrillation after noncardiac surgery. J Am Coll Surg 2014; 219:831.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/9\" class=\"nounderline abstract_t\">January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130:e199.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/10\" class=\"nounderline abstract_t\">Drew BJ, Scheinman MM. ECG criteria to distinguish between aberrantly conducted supraventricular tachycardia and ventricular tachycardia: practical aspects for the immediate care setting. Pacing Clin Electrophysiol 1995; 18:2194.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/11\" class=\"nounderline abstract_t\">Link MS, Atkins DL, Passman RS, et al. Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S706.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/12\" class=\"nounderline abstract_t\">Bengali R, Wellens HJ, Jiang Y. Perioperative management of the Wolff-Parkinson-White syndrome. J Cardiothorac Vasc Anesth 2014; 28:1375.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/13\" class=\"nounderline abstract_t\">Kim RJ, Gerling BR, Kono AT, Greenberg ML. Precipitation of ventricular fibrillation by intravenous diltiazem and metoprolol in a young patient with occult Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol 2008; 31:776.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/14\" class=\"nounderline abstract_t\">Mayet S, Gossop M, Lintzeris N, et al. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev 2011; 30:388.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/15\" class=\"nounderline abstract_t\">Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005; 14:747.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/16\" class=\"nounderline abstract_t\">Charbit B, Albaladejo P, Funck-Brentano C, et al. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005; 102:1094.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/17\" class=\"nounderline abstract_t\">Charbit B, Alvarez JC, Dasque E, et al. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Anesthesiology 2008; 109:206.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/18\" class=\"nounderline abstract_t\">Lischke V, Wilke HJ, Probst S, et al. Prolongation of the QT-interval during induction of anesthesia in patients with coronary artery disease. Acta Anaesthesiol Scand 1994; 38:144.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/19\" class=\"nounderline abstract_t\">Korpinen R, Saarnivaara L, Siren K. QT interval of the ECG, heart rate and arterial pressure during anaesthetic induction: comparative effects of alfentanil and esmolol. Acta Anaesthesiol Scand 1995; 39:809.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/20\" class=\"nounderline abstract_t\">Zaballos M, Jimeno C, Almendral J, et al. Cardiac electrophysiological effects of remifentanil: study in a closed-chest porcine model. Br J Anaesth 2009; 103:191.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/21\" class=\"nounderline abstract_t\">Michaloudis DG, Kanakoudis FS, Xatzikraniotis A, Bischiniotis TS. The effects of midazolam followed by administration of either vecuronium or atracurium on the QT interval in humans. Eur J Anaesthesiol 1995; 12:577.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/22\" class=\"nounderline abstract_t\">Erdil F, Demirbilek S, Begec Z, et al. Effects of propofol or etomidate on QT interval during electroconvulsive therapy. J ECT 2009; 25:174.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/23\" class=\"nounderline abstract_t\">Mitchell GF, Jeron A, Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol 1998; 274:H747.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/24\" class=\"nounderline abstract_t\">Michaloudis DG, Kanakoudis FS, Petrou AM, et al. The effects of midazolam or propofol followed by suxamethonium on the QT interval in humans. Eur J Anaesthesiol 1996; 13:364.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/25\" class=\"nounderline abstract_t\">Saarnivaara L, Klemola UM, Lindgren L, et al. QT interval of the ECG, heart rate and arterial pressure using propofol, methohexital or midazolam for induction of anaesthesia. Acta Anaesthesiol Scand 1990; 34:276.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/26\" class=\"nounderline abstract_t\">Saarnivaara L, Klemola UM, Lindgren L. QT interval of the ECG, heart rate and arterial pressure using five non-depolarizing muscle relaxants for intubation. Acta Anaesthesiol Scand 1988; 32:623.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/27\" class=\"nounderline abstract_t\">de Kam PJ, van Kuijk J, Prohn M, et al. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. Clin Drug Investig 2010; 30:599.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/28\" class=\"nounderline abstract_t\">de Kam PJ, van Kuijk J, Smeets J, et al. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study. Int J Clin Pharmacol Ther 2012; 50:595.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/29\" class=\"nounderline abstract_t\">Knudsen K, Beckman Suurk&uuml;la M, Blomberg S, et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997; 78:507.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/30\" class=\"nounderline abstract_t\">Owczuk R, Wujtewicz MA, Sawicka W, et al. The effect of intravenous lidocaine on QT changes during tracheal intubation. Anaesthesia 2008; 63:924.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/31\" class=\"nounderline abstract_t\">Gratadour P, Viale JP, Parlow J, et al. Sympathovagal effects of spinal anesthesia assessed by the spontaneous cardiac baroreflex. Anesthesiology 1997; 87:1359.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/32\" class=\"nounderline abstract_t\">Lesser JB, Sanborn KV, Valskys R, Kuroda M. Severe bradycardia during spinal and epidural anesthesia recorded by an anesthesia information management system. Anesthesiology 2003; 99:859.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/33\" class=\"nounderline abstract_t\">Caplan RA, Ward RJ, Posner K, Cheney FW. Unexpected cardiac arrest during spinal anesthesia: a closed claims analysis of predisposing factors. Anesthesiology 1988; 68:5.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/34\" class=\"nounderline abstract_t\">Keats AS. Anesthesia mortality--a new mechanism. Anesthesiology 1988; 68:2.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/35\" class=\"nounderline abstract_t\">Kinsella SM, Tuckey JP. Perioperative bradycardia and asystole: relationship to vasovagal syncope and the Bezold-Jarisch reflex. Br J Anaesth 2001; 86:859.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/36\" class=\"nounderline abstract_t\">Liu W, Bidwai AV, Stanley TH, Isern-Amaral J. Cardiovascular dynamics after large doses of fentanyl and fentanyl plus N2O in the dog. Anesth Analg 1976; 55:168.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/37\" class=\"nounderline abstract_t\">Prakash O, Verdouw PD, de Jong JW, et al. Haemodynamic and biochemical variables after induction of anaesthesia with fentanyl and nitrous oxide in patients undergoing coronary artery by-pass surgery. Can Anaesth Soc J 1980; 27:223.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/38\" class=\"nounderline abstract_t\">DeSouza G, Lewis MC, TerRiet MF. Severe bradycardia after remifentanil. Anesthesiology 1997; 87:1019.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/39\" class=\"nounderline abstract_t\">Bennett JA, Abrams JT, Van Riper DF, Horrow JC. Difficult or impossible ventilation after sufentanil-induced anesthesia is caused primarily by vocal cord closure. Anesthesiology 1997; 87:1070.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/40\" class=\"nounderline abstract_t\">Coruh B, Tonelli MR, Park DR. Fentanyl-induced chest wall rigidity. Chest 2013; 143:1145.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/41\" class=\"nounderline abstract_t\">Gravlee GP, Ramsey FM, Roy RC, et al. Rapid administration of a narcotic and neuromuscular blocker: a hemodynamic comparison of fentanyl, sufentanil, pancuronium, and vecuronium. Anesth Analg 1988; 67:39.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/42\" class=\"nounderline abstract_t\">Hodzic S, Golic D, Smajic J, et al. Complications Related to Insertion and Use of Central Venous Catheters (CVC). Med Arch 2014; 68:300.</a></li><li><a href=\"https://www.uptodate.com/contents/arrhythmias-during-anesthesia/abstract/43\" class=\"nounderline abstract_t\">Sprung CL, Elser B, Schein RM, et al. Risk of right bundle-branch block and complete heart block during pulmonary artery catheterization. Crit Care Med 1989; 17:1.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 94357 Version 10.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H754484273\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H3340866184\" id=\"outline-link-H3340866184\">INTRODUCTION</a></li><li><a href=\"#H3806099833\" id=\"outline-link-H3806099833\">INTRAOPERATIVE DIAGNOSIS OF ARRHYTHMIAS</a><ul><li><a href=\"#H1282227149\" id=\"outline-link-H1282227149\">Standard electrocardiography</a></li><li><a href=\"#H3063513053\" id=\"outline-link-H3063513053\">Recognition of artifacts</a></li></ul></li><li><a href=\"#H1841031312\" id=\"outline-link-H1841031312\">CONTRIBUTING FACTORS</a><ul><li><a href=\"#H914741745\" id=\"outline-link-H914741745\">Myocardial ischemia</a></li><li><a href=\"#H2266952436\" id=\"outline-link-H2266952436\">Extracardiac causes of cardiac pump failure</a></li><li><a href=\"#H1444722565\" id=\"outline-link-H1444722565\">Respiratory, metabolic, volume status, and electrolyte abnormalities</a></li></ul></li><li><a href=\"#H140932897\" id=\"outline-link-H140932897\">ATRIAL TACHYARRHYTHMIAS</a><ul><li><a href=\"#H1843426040\" id=\"outline-link-H1843426040\">Urgent management</a></li><li><a href=\"#H584733046\" id=\"outline-link-H584733046\">Narrow QRS complex atrial tachycardias</a><ul><li><a href=\"#H4049472522\" id=\"outline-link-H4049472522\">- Sinus tachycardia</a></li><li><a href=\"#H2381976445\" id=\"outline-link-H2381976445\">- Atrial fibrillation</a></li><li><a href=\"#H2466304913\" id=\"outline-link-H2466304913\">- Atrial flutter</a></li><li><a href=\"#H3322910683\" id=\"outline-link-H3322910683\">- Atrioventricular nodal reentrant tachycardia</a></li><li><a href=\"#H2498766903\" id=\"outline-link-H2498766903\">- Multifocal atrial tachycardia</a></li></ul></li><li><a href=\"#H3076912183\" id=\"outline-link-H3076912183\">Wide QRS complex atrial tachycardias</a><ul><li><a href=\"#H3107053684\" id=\"outline-link-H3107053684\">- Supraventricular tachycardia with aberrant conduction</a></li><li><a href=\"#H2262937916\" id=\"outline-link-H2262937916\">- Wolff-Parkinson-White syndrome</a></li></ul></li></ul></li><li><a href=\"#H412752339\" id=\"outline-link-H412752339\">VENTRICULAR ARRHYTHMIAS</a><ul><li><a href=\"#H100846285\" id=\"outline-link-H100846285\">Emergency management</a></li><li><a href=\"#H1290779637\" id=\"outline-link-H1290779637\">Ventricular fibrillation</a></li><li><a href=\"#H2150709257\" id=\"outline-link-H2150709257\">Monomorphic ventricular tachycardia</a></li><li><a href=\"#H2547867389\" id=\"outline-link-H2547867389\">Polymorphic ventricular tachycardia (torsades de pointes)</a><ul><li><a href=\"#H3641817214\" id=\"outline-link-H3641817214\">- Prolonged QT interval: Perioperative medications that increase risk</a></li></ul></li><li><a href=\"#H3424506429\" id=\"outline-link-H3424506429\">Nonsustained ventricular tachycardia</a></li><li><a href=\"#H875200345\" id=\"outline-link-H875200345\">Premature ventricular contractions</a></li><li><a href=\"#H1913350269\" id=\"outline-link-H1913350269\">Ventricular paced rhythms</a></li></ul></li><li><a href=\"#H1803355460\" id=\"outline-link-H1803355460\">BRADYARRHYTHMIAS</a><ul><li><a href=\"#H3749139260\" id=\"outline-link-H3749139260\">Urgent management</a><ul><li><a href=\"#H1600607570\" id=\"outline-link-H1600607570\">- Pharmacologic agents</a></li><li><a href=\"#H2806807069\" id=\"outline-link-H2806807069\">- Temporary pacing</a><ul><li><a href=\"#H1096910346\" id=\"outline-link-H1096910346\">Transcutaneous pacing</a></li><li><a href=\"#H522983336\" id=\"outline-link-H522983336\">Transvenous pacing</a></li><li><a href=\"#H1410735157\" id=\"outline-link-H1410735157\">Pacing pulmonary artery catheters</a></li><li><a href=\"#H1170835862\" id=\"outline-link-H1170835862\">Transesophageal pacing</a></li></ul></li></ul></li><li><a href=\"#H3843570580\" id=\"outline-link-H3843570580\">Sinus bradycardia</a><ul><li><a href=\"#H2224933693\" id=\"outline-link-H2224933693\">- Vagal reflexes</a></li><li><a href=\"#H1292176759\" id=\"outline-link-H1292176759\">- Neuraxial anesthesia</a></li><li><a href=\"#H3321066379\" id=\"outline-link-H3321066379\">- Medications</a></li></ul></li><li><a href=\"#H2280974143\" id=\"outline-link-H2280974143\">Sick sinus syndrome</a></li><li><a href=\"#H3389975165\" id=\"outline-link-H3389975165\">Bundle branch blocks</a></li><li><a href=\"#H1720547143\" id=\"outline-link-H1720547143\">Conduction defects</a></li><li><a href=\"#H3480950092\" id=\"outline-link-H3480950092\">Asystole</a></li></ul></li><li><a href=\"#H1088736258\" id=\"outline-link-H1088736258\">SPECIAL PERIOPERATIVE SITUATIONS</a><ul><li><a href=\"#H2876333685\" id=\"outline-link-H2876333685\">Intrathoracic procedures</a></li><li><a href=\"#H3347731549\" id=\"outline-link-H3347731549\">Intravascular interventions</a></li><li><a href=\"#H2226791375\" id=\"outline-link-H2226791375\">Local anesthetic toxicity</a></li><li><a href=\"#H1299032942\" id=\"outline-link-H1299032942\">Electroconvulsive therapy</a></li></ul></li><li><a href=\"#H3216529387\" id=\"outline-link-H3216529387\">POSTOPERATIVE MANAGEMENT</a></li><li><a href=\"#H1116023503\" id=\"outline-link-H1116023503\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H754484273\" id=\"outline-link-H754484273\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ANEST/94357|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=EM/62714\" class=\"graphic graphic_algorithm\">- Adult tachycardia algorithm</a></li><li><a href=\"image.htm?imageKey=EM/73862\" class=\"graphic graphic_algorithm\">- Adult cardiac arrest algorithm</a></li><li><a href=\"image.htm?imageKey=EM/63919\" class=\"graphic graphic_algorithm\">- Adult bradycardia algorithm</a></li></ul></li><li><div id=\"ANEST/94357|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/103268\" class=\"graphic graphic_figure\">- Hands-free pacemaker/defibrillator pad positioning</a></li></ul></li><li><div id=\"ANEST/94357|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/52416\" class=\"graphic graphic_table\">- Treatable conditions associated with cardiac arrest</a></li><li><a href=\"image.htm?imageKey=ANEST/110671\" class=\"graphic graphic_table\">- Pharmacologic treatment of intraoperative arrhythmias</a></li><li><a href=\"image.htm?imageKey=ANEST/96387\" class=\"graphic graphic_table\">- Vasoactive infusions used in the operating room: Adult dosing</a></li><li><a href=\"image.htm?imageKey=ANEST/110771\" class=\"graphic graphic_table\">- ECG effects of anesthetic agents</a></li><li><a href=\"image.htm?imageKey=PULM/99963\" class=\"graphic graphic_table\">- Vasopressors and inotropes</a></li><li><a href=\"image.htm?imageKey=ANEST/107887\" class=\"graphic graphic_table\">- Local anesthetic systemic toxicity: Rapid overview</a></li></ul></li><li><div id=\"ANEST/94357|Waveform\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"WAVEFORMS\">WAVEFORMS</a></div><ul><li><a href=\"image.htm?imageKey=CARD/66206\" class=\"graphic graphic_waveform\">- Prolonged QT</a></li><li><a href=\"image.htm?imageKey=CARD/78938\" class=\"graphic graphic_waveform\">- ECG strip sinus tachycardia</a></li><li><a href=\"image.htm?imageKey=CARD/73958\" class=\"graphic graphic_waveform\">- ECG atrial fibrillation 1</a></li><li><a href=\"image.htm?imageKey=CARD/62698\" class=\"graphic graphic_waveform\">- Atrial fibrillation tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/53988\" class=\"graphic graphic_waveform\">- ECG atrial fibrillation 2</a></li><li><a href=\"image.htm?imageKey=CARD/74395\" class=\"graphic graphic_waveform\">- Typical atrial flutter</a></li><li><a href=\"image.htm?imageKey=CARD/57001\" class=\"graphic graphic_waveform\">- 12 lead ECG common AVNRT</a></li><li><a href=\"image.htm?imageKey=CARD/81639\" class=\"graphic graphic_waveform\">- 12 lead ECG uncommon AVNRT</a></li><li><a href=\"image.htm?imageKey=CARD/70173\" class=\"graphic graphic_waveform\">- ECG multifocal atrial tachycardia</a></li><li><a href=\"image.htm?imageKey=CARD/80454\" class=\"graphic graphic_waveform\">- ECG Ventricular fibrillation tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/63176\" class=\"graphic graphic_waveform\">- ECG Monomorphic VT tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/81690\" class=\"graphic graphic_waveform\">- ECG RMVT from LVOT</a></li><li><a href=\"image.htm?imageKey=CARD/65800\" class=\"graphic graphic_waveform\">- Ventricular flutter tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/53891\" class=\"graphic graphic_waveform\">- ECG Torsades de pointes tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/73299\" class=\"graphic graphic_waveform\">- ECG nonsustained ventricular tachycardia</a></li><li><a href=\"image.htm?imageKey=CARD/57511\" class=\"graphic graphic_waveform\">- ECG ventricular premature beat tutorial</a></li><li><a href=\"image.htm?imageKey=CARD/64812\" class=\"graphic graphic_waveform\">- ECG biventricular pacing</a></li><li><a href=\"image.htm?imageKey=CARD/52675\" class=\"graphic graphic_waveform\">- ECG strip sinus bradycardia</a></li><li><a href=\"image.htm?imageKey=CARD/61594\" class=\"graphic graphic_waveform\">- ECG Left bundle branch block 2</a></li><li><a href=\"image.htm?imageKey=CARD/64393\" class=\"graphic graphic_waveform\">- ECG right bundle branch block 2</a></li><li><a href=\"image.htm?imageKey=CARD/115972\" class=\"graphic graphic_waveform\">- ECG left anterior fascicular block</a></li><li><a href=\"image.htm?imageKey=CARD/116957\" class=\"graphic graphic_waveform\">- ECG left posterior fascicular block</a></li><li><a href=\"image.htm?imageKey=CARD/67882\" class=\"graphic graphic_waveform\">- ECG first degree AV block I</a></li><li><a href=\"image.htm?imageKey=CARD/73051\" class=\"graphic graphic_waveform\">- ECG Mobitz type I AV block</a></li><li><a href=\"image.htm?imageKey=CARD/79539\" class=\"graphic graphic_waveform\">- ECG Mobitz type II AV block</a></li><li><a href=\"image.htm?imageKey=CARD/58649\" class=\"graphic graphic_waveform\">- Mobitz type II second degree atrioventricular block</a></li><li><a href=\"image.htm?imageKey=CARD/72863\" class=\"graphic graphic_waveform\">- ECG third degree or complete AV block</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=advanced-cardiac-life-support-acls-in-adults\" class=\"medical medical_review\">Advanced cardiac life support (ACLS) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease\" class=\"medical medical_review\">Anesthesia for noncardiac surgery in patients with ischemic heart disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthetic-considerations-for-electrophysiology-interventional-cardiology-and-transesophageal-echocardiography-procedures\" class=\"medical medical_review\">Anesthetic considerations for electrophysiology, interventional cardiology, and transesophageal echocardiography procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-diagnosis-of-wide-qrs-complex-tachycardias\" class=\"medical medical_review\">Approach to the diagnosis of wide QRS complex tachycardias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atrial-fibrillation-cardioversion-to-sinus-rhythm\" class=\"medical medical_review\">Atrial fibrillation: Cardioversion to sinus rhythm</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atrioventricular-nodal-reentrant-tachycardia\" class=\"medical medical_review\">Atrioventricular nodal reentrant tachycardia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=basic-principles-and-technique-of-electrical-cardioversion-and-defibrillation\" class=\"medical medical_review\">Basic principles and technique of electrical cardioversion and defibrillation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiopulmonary-bypass-management\" class=\"medical medical_review\">Cardiopulmonary bypass: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardioversion-for-specific-arrhythmias\" class=\"medical medical_review\">Cardioversion for specific arrhythmias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-and-treatment-of-hypermagnesemia\" class=\"medical medical_review\">Causes and treatment of hypermagnesemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-hypokalemia-in-adults\" class=\"medical medical_review\">Clinical manifestations and treatment of hypokalemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-hypercalcemia\" class=\"medical medical_review\">Clinical manifestations of hypercalcemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-hyperkalemia-in-adults\" class=\"medical medical_review\">Clinical manifestations of hyperkalemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-hypocalcemia\" class=\"medical medical_review\">Clinical manifestations of hypocalcemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-magnesium-depletion\" class=\"medical medical_review\">Clinical manifestations of magnesium depletion</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-narrow-qrs-complex-tachycardias\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia\" class=\"medical medical_review\">Clinical use of neuromuscular blocking agents in anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=control-of-ventricular-rate-in-atrial-fibrillation-pharmacologic-therapy\" class=\"medical medical_review\">Control of ventricular rate in atrial fibrillation: Pharmacologic therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=electrocardiographic-and-electrophysiologic-features-of-atrial-flutter\" class=\"medical medical_review\">Electrocardiographic and electrophysiologic features of atrial flutter</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-treatment-of-hypomagnesemia\" class=\"medical medical_review\">Evaluation and treatment of hypomagnesemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=first-degree-atrioventricular-block\" class=\"medical medical_review\">First degree atrioventricular block</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=left-anterior-fascicular-block\" class=\"medical medical_review\">Left anterior fascicular block</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=left-bundle-branch-block\" class=\"medical medical_review\">Left bundle branch block</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=left-posterior-fascicular-block\" class=\"medical medical_review\">Left posterior fascicular block</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=local-anesthetic-systemic-toxicity\" class=\"medical medical_review\">Local anesthetic systemic toxicity</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=monitoring-during-anesthesia\" class=\"medical medical_review\">Monitoring during anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=multifocal-atrial-tachycardia\" class=\"medical medical_review\">Multifocal atrial tachycardia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nonsustained-ventricular-tachycardia-clinical-manifestations-evaluation-and-management\" class=\"medical medical_review\">Nonsustained ventricular tachycardia: Clinical manifestations, evaluation, and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-acute-management-of-tachyarrhythmias\" class=\"medical medical_review\">Overview of the acute management of tachyarrhythmias</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-management-of-patients-with-a-pacemaker-or-implantable-cardioverter-defibrillator\" class=\"medical medical_review\">Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postoperative-nausea-and-vomiting\" class=\"medical medical_review\">Postoperative nausea and vomiting</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=right-bundle-branch-block\" class=\"medical medical_review\">Right bundle branch block</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=role-of-antiarrhythmic-drugs-for-ventricular-arrhythmias-in-patients-with-a-prior-myocardial-infarction\" class=\"medical medical_review\">Role of antiarrhythmic drugs for ventricular arrhythmias in patients with a prior myocardial infarction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=second-degree-atrioventricular-block-mobitz-type-i-wenckebach-block\" class=\"medical medical_review\">Second degree atrioventricular block: Mobitz type I (Wenckebach block)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=second-degree-atrioventricular-block-mobitz-type-ii\" class=\"medical medical_review\">Second degree atrioventricular block: Mobitz type II</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sick-sinus-syndrome-clinical-manifestations-diagnosis-and-evaluation\" class=\"medical medical_review\">Sick sinus syndrome: Clinical manifestations, diagnosis, and evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sick-sinus-syndrome-treatment\" class=\"medical medical_review\">Sick sinus syndrome: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sinus-bradycardia\" class=\"medical medical_review\">Sinus bradycardia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sinus-tachycardia-evaluation-and-management\" class=\"medical medical_review\">Sinus tachycardia: Evaluation and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-arrhythmias-in-adults\" class=\"medical medical_society_guidelines\">Society guideline links: Arrhythmias in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-basic-and-advanced-cardiac-life-support-in-adults\" class=\"medical medical_society_guidelines\">Society guideline links: Basic and advanced cardiac life support in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=symptoms-of-hypermagnesemia\" class=\"medical medical_review\">Symptoms of hypermagnesemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=technique-for-performing-electroconvulsive-therapy-ect-in-adults\" class=\"medical medical_review\">Technique for performing electroconvulsive therapy (ECT) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=temporary-cardiac-pacing\" class=\"medical medical_review\">Temporary cardiac pacing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-electrocardiogram-in-atrial-fibrillation\" class=\"medical medical_review\">The electrocardiogram in atrial fibrillation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=third-degree-complete-atrioventricular-block\" class=\"medical medical_review\">Third degree (complete) atrioventricular block</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-hyperkalemia-in-adults\" class=\"medical medical_review\">Treatment and prevention of hyperkalemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-hypercalcemia\" class=\"medical medical_review\">Treatment of hypercalcemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-hypocalcemia\" class=\"medical medical_review\">Treatment of hypocalcemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-symptomatic-arrhythmias-associated-with-the-wolff-parkinson-white-syndrome\" class=\"medical medical_review\">Treatment of symptomatic arrhythmias associated with the Wolff-Parkinson-White syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ventricular-premature-beats\" class=\"medical medical_review\">Ventricular premature beats</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=wide-qrs-complex-tachycardias-approach-to-management\" class=\"medical medical_review\">Wide QRS complex tachycardias: Approach to management</a></li></ul></div></div>","javascript":null}